Edition:
United Kingdom

Insider Trading: Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

107.95USD
3:36pm BST
Change (% chg)

$-0.59 (-0.54%)
Prev Close
$108.54
Open
$108.86
Day's High
$108.99
Day's Low
$107.90
Volume
86,951
Avg. Vol
710,078
52-wk High
$141.81
52-wk Low
$92.57

All Insider Trades
Trading Date Name Title Type Shares Traded Price
11 Jul 2019

Clancy (Paul J.)

Chief Financial Officer Sell 5,230 $124.20
1 Jul 2019

Lall (Franchini Indrani)

Officer Sell 4,500 $132.78
21 Jun 2019

Sarin (Aradhana)

Officer Sell 578 $132.00
7 Jun 2019

Law (Anne-Marie)

Officer Sell 2,563 $118.61
7 Jun 2019

Orloff (John J M.D.)

Officer Sell 2,786 $118.61
7 Jun 2019

Goff (Brian)

Officer Sell 1,643 $118.61
7 Jun 2019

Lall (Franchini Indrani)

Officer Sell 1,404 $118.61
30 May 2019

BAKER BROS ADVISORS L P

Director Sell 1,845 $120.12
30 May 2019

BAKER BROS ADVISORS L P

Director Sell 2,729 $120.77
30 May 2019

BAKER BROS ADVISORS L P

Director Sell 1,587 $122.31
30 May 2019

BAKER BROS ADVISORS L P

Director Sell 15,355 $120.12
30 May 2019

BAKER BROS ADVISORS L P

Director Sell 22,720 $120.77
30 May 2019

BAKER BROS ADVISORS L P

Director Sell 13,213 $122.31
29 May 2019

BAKER BROS ADVISORS L P

Director Sell 3,696 $123.06
29 May 2019

BAKER BROS ADVISORS L P

Director Sell 4,300 $122.37
29 May 2019

BAKER BROS ADVISORS L P

Director Sell 35,796 $122.37
29 May 2019

BAKER BROS ADVISORS L P

Director Sell 30,766 $123.06
29 May 2019

BAKER BROS ADVISORS L P

Director Sell 4,772 $121.37
29 May 2019

BAKER BROS ADVISORS L P

Director Sell 39,732 $121.37
28 May 2019

BAKER BROS ADVISORS L P

Director Sell 1,867 $126.25
28 May 2019

BAKER BROS ADVISORS L P

Director Sell 2,749 $125.05
28 May 2019

BAKER BROS ADVISORS L P

Director Sell 8,627 $127.06
28 May 2019

BAKER BROS ADVISORS L P

Director Sell 15,541 $126.25
28 May 2019

BAKER BROS ADVISORS L P

Director Sell 71,819 $127.06
28 May 2019

BAKER BROS ADVISORS L P

Director Sell 22,886 $125.05

Institutional Holders

% Shares Owned: 97.89%
# of Holders: 955
Total Shares Held: 219,491,001
3 Mo. Net Change: -1,758,830
# New Positions: 105
# Closed Positions: 70
# Increased Positions: 438
# Reduced Positions: 345
# Net Buyers: 93

Officers & Directors

Name Age Since Current Position

David Brennan

65 2017 Independent Chairman of the Board

Ludwig Hantson

56 2017 Chief Executive Officer, Director

Paul Clancy

57 2017 Chief Financial Officer, Executive Vice President

Indrani Franchini

47 2017 Executive Vice President, Chief Compliance Officer

Ellen Chiniara

60 2018 Executive Vice President, General Counsel, Corporate Secretary

Anne-Marie Law

51 2019 Chief Patient and Employee Experience Officer, Executive Vice President

John Orloff

61 2017 Executive Vice President, Head of Research and Development

Brian Goff

49 2017 Chief Commercial Officer, Executive Vice President

Felix Baker

50 2015 Independent Director

Christopher Coughlin

66 2014 Independent Director

Deborah Dunsire

57 2018 Independent Director

Paul Friedman

76 2017 Independent Director

John Mollen

68 2014 Independent Director

Francois Nader

62 2017 Independent Director

Judith Reinsdorf

55 2018 Independent Director

Andreas Rummelt

62 2010 Independent Director